Historical record - last NADAC effective date: 4/19/2017
Product Information
LOPREEZA 0.5 MG-0.1 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $2.6752 per EA under NDC 69238125208. Its NADAC has been published 125 times since Dec 10, 2014.
FDA first approved this application on Nov 18, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; .1 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238125208
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/19/2017
Active Ingredients
ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020907FDA Approved
11/18/1998
TE Code
AB
On Market Since
10/1/2014
Price Statistics
The NADAC for LOPREEZA 0.5 MG-0.1 MG TABLET has been published 125 times since Dec 10, 2014, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6752 per EA |
|---|---|
| All-time high | $3.3260 (Feb 11, 2015) |
| All-time low | $2.6752 (Apr 19, 2017) |
| Median price | $3.1760 |
| Average price | $3.1573 |
| Largest weekly change | +6.8% (Feb 22, 2017) |
| Weeks tracked | 125 |
| Tracking since | Dec 10, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-17.5%
Last surveyed Apr 26, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estradiol/norethindrone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol/norethindrone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOPREEZA 0.5 MG-0.1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LOPREEZA 0.5 MG-0.1 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $2.6752 per EA (NDC 69238125208), effective Apr 26, 2017.
How has the price of LOPREEZA 0.5 MG-0.1 MG TABLET changed over time?
Over the history we have for it, the NADAC for LOPREEZA 0.5 MG-0.1 MG TABLET has declined 17.5%. It has been tracked across 125 weekly CMS publications since Dec 10, 2014.
What are the highest and lowest recorded NADAC prices for LOPREEZA 0.5 MG-0.1 MG TABLET?
Since Dec 10, 2014, the NADAC for LOPREEZA 0.5 MG-0.1 MG TABLET has ranged from a low of $2.6752 (Apr 19, 2017) to a high of $3.3260 (Feb 11, 2015), with a median of $3.1760 per EA.
Are there cheaper alternatives to LOPREEZA 0.5 MG-0.1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LOPREEZA 0.5 MG-0.1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOPREEZA 0.5 MG-0.1 MG TABLET?
LOPREEZA 0.5 MG-0.1 MG TABLET (NDC 69238125208) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.